Synspira Therapeutics and Cystic Fibrosis Foundation Sign Agreement to Develop Broad-spectrum Enzyme Replacement for Malabsorption Syndromes Posted on February 12, 2020February 12, 2020 by Steve Polito Continue reading “Synspira Therapeutics and Cystic Fibrosis Foundation Sign Agreement to Develop Broad-spectrum Enzyme Replacement for Malabsorption Syndromes”
Synspira Therapeutics Announces Appointment of Robert Gallotto as President and Chief Executive Officer Posted on March 27, 2019March 27, 2019 by Steve Polito Continue reading “Synspira Therapeutics Announces Appointment of Robert Gallotto as President and Chief Executive Officer”
Toggle navigation